403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
1st MERS casualty reported in Oman
(MENAFN- Arab News) Muscat: Oman reported Thursday its first death of a person from Middle East Respiratory Syndrome coronavirus (MERS-CoV) in nearly a year.
No further details were given in the Health Ministry statement carried by the official ONA news agency. It is the third MERS fatality in the Gulf sultanate.
Oman borders Saudi Arabia the country hardest hit by MERS.
MERS is considered a deadlier but less transmissible cousin of the SARS virus that appeared in Asia in 2003 and infected more than 8000 people nine percent of whom died.
Like SARS it appears to cause a lung infection with patients suffering coughing breathing difficulties and a temperature. But MERS differs in that it can cause rapid kidney failure.
Research by Saudi scientists indicates that camels play a role in the transmission of the virus to humans.
Mers exhibits a 40 percent fatality rate and more than 97 percent of the cases have occurred in the Middle East.
No further details were given in the Health Ministry statement carried by the official ONA news agency. It is the third MERS fatality in the Gulf sultanate.
Oman borders Saudi Arabia the country hardest hit by MERS.
MERS is considered a deadlier but less transmissible cousin of the SARS virus that appeared in Asia in 2003 and infected more than 8000 people nine percent of whom died.
Like SARS it appears to cause a lung infection with patients suffering coughing breathing difficulties and a temperature. But MERS differs in that it can cause rapid kidney failure.
Research by Saudi scientists indicates that camels play a role in the transmission of the virus to humans.
Mers exhibits a 40 percent fatality rate and more than 97 percent of the cases have occurred in the Middle East.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment